GLP-1 and glucagon secretion from a pancreatic neuroendocrine tumor causing diabetes and hyperinsulinemic hypoglycemia

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3039-3045

  Roberts, Rachel E ^a   Zhao, Min ^a   Whitelaw, Ben C ^b   Ramage, John ^b   Diaz Cano, Salvador ^b   Le Roux, Carel W ^b   Quaglia, Alberto ^b   Huang, Guo Cai ^a   Aylwin, Simon J B ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHROMOGRANIN A; GLICLAZIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; METFORMIN; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; BIOASSAY; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; EX VIVO STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERINSULINEMIC HYPOGLYCEMIA; HYPOGLYCEMIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; LIVER METASTASIS; LIVER RESECTION; MALE; MEDICAL HISTORY; MOLECULAR PATHOLOGY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS RESECTION; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN SECRETION; SPLENECTOMY; TREATMENT PLANNING;

ADENOMA, ISLET CELL; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HEPATECTOMY; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATECTOMY; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SPLENECTOMY;

MUS; MUS MUSCULUS;

EID: 84866173363     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2005     Document Type: Article

References (36)

1. Svartberg J, Stridsberg M, Wilander E, Andersson DE, Eriksson B 1996 Tumour induced hypoglycaemia in a patient with insulin dependent diabetes mellitus. J Intern Med 239:181-185 (Pubitemid 26043153)
2. Sandler R, Horwitz DL, Rubenstein AH, Kuzuya H 1975 Hypoglycaemia and endogenous hyperinsulinaemia complicating diabetes mellitus. Am J Med 59:730-736
3. Bell DS, Grizzle WE, Dunlap NE 1995 Nesidioblastosis causing reversal of insulin-dependent diabetes and development of hyperinsulinaemic hypoglycaemia. Diabetes Care 18:1379-1380
4. Kon YC, Loh KC, Chew SP, Wong D, Yap WM, Lee YS, Low CH 2000 Hypoglycaemia from islet cell hyperplasia and nesidioblastosis in a patient with type 2 diabetes mellitus - a case report. Ann Acad Med Singapore 29:682-687
5. Raffel A, Anlauf M, Hosch SB, Krausch M, Henopp T, Bauersfeld J, Klofat R, Bach D, Eisenberger CF, Kloppel G, Knoefel WT 2006 Hyperinsulinemic hypoglycemia due to adult nesidioblastosis in insulin-dependent diabetes. World J Gastroenterol 12:7221-7224 (Pubitemid 44890660)
6. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV 2005 Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249-254 (Pubitemid 41058324)
7. Dhanvantari S, Seidah NG, Brubaker PL 1996 Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol 10:342-355 (Pubitemid 26112399)
8. Todd JF, Stanley SA, Roufosse CA, Bishop AE, Khoo B, Bloom SR, Meeran K 2003 A tumour that secretes glucagon like peptide 1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet 361:228-230 (Pubitemid 36126227)
9. Kreymann B, Williams G, Ghatei MA, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304 (Pubitemid 17156636)
10. Bloom SR, Long RG 1982 Radioimmunoassay of gut regulatory peptides. Philadelphia: W. B. Saunders Company Ltd
11. Ghatei MA, Uttenthal LO, Bryant MG, Christofides ND, Moody AJ, Bloom SR 1983 Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas. Endocrinology 112:917-923
12. Rae MV, Lewis RC 1957 Islet cell tumour in diabetes mellitus: report of two cases. Can Med Assoc J 77:691-694
13. Kane LA, Grant CS, Nippoldt TB, Service FJ 1993 Insulinoma in a patient with NIDDM. Diabetes Care 16:1298-1300 (Pubitemid 23259874)
14. Grunberger G 1993 Insulin resistance in a case of coexisting insulinoma and type 2 diabetes. Acta Diabetol 30:243-250 (Pubitemid 24052990)
15. Sakurai A, Aizawa T, Katakura M, Sato Y, Kaneko G, Yoshizawa K, Hashizume K 1997 Insulinoma in a patient with non-insulin-dependent diabetes mellitus. Endocr J 44:473-477 (Pubitemid 27406753)
16. Wildbrett J, Nagel M, Theissig F, Gaertner HJ, Gromeier S, Fischer S, Hanefeld M 1999 An unusual picture of insulinoma in type-2 diabetes mellitus and morbid obesity. Dtsch Med Wochenschr 124:248-252 (Pubitemid 29142588)
17. Levine RA, Sobel BE 2001 Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I. Coron Artery Dis 12:333-336 (Pubitemid 32547889)
18. Nagai T, Imamura M, Takai Y, Mori M 2003 Insulinoma accompanied by diabetes mellitus. Diabetes Res Clin Pract 60:19-23 (Pubitemid 36299249)
19. Sapountzi P, Charnogursky G, Emanuele MA, Murphy D, Nabhan F, Emanuele NV 2005 Case study: diagnosis of insulinoma using continuous glucose monitoring system in a patient with diabetes. Clin Diabetes 23:140-143 (Pubitemid 41126810)
20. Hameed MF, Hoyle GE, Muir Z 2006 A mysterious case of normalising blood sugar: insulinoma in a long-standing diabetic patient. Age Ageing 35:317-318
21. Lei WY, Wang TE, Chen TL, Chang WH, Yang TL, Wang CY 2007 Insulinoma causing hypoglycemia in a patient with type 2 diabetes. J Formos Med Assoc 106:392-396
22. Heni M, Schott S, Horger M, Dudziak K, Thamer C, Häring HU, Fritsche A, Müssig K 2009 A rare cause of hypoglycaemia in a patient with type 2 diabetes. Dtsch Med Wochenschr 134:F2
23. Atkinson AB, Buchanan KD, Carson DJ, Kennedy T, O'Hare MM, Sloan JM, Hadden DR 1978 Insulinoma (apud cell carcinoma) in a diabetic. Br Med J 2:1397-1398 (Pubitemid 9048727)
24. Dhillo WS, Meeran K, Todd JF 2004 Metastatic glucagonoma de-differentiated to an insulinoma: response to embolization. Presented at British Endocrine Societies Joint Meeting, Brighton, UK, 2004. Endocrine Abstracts 7:112
25. Siraj ES, Samuel G, Saber S, Samuel S, Hamrahian AH, Reddy SS 2006 Metastatic malignant insulinoma in a patient with type 2 diabetes mellitus: case presentation and literature review. Endocr Pract 12:411-416 (Pubitemid 44717601)
26. Iqbal N, Byard A, Singh BM, Buch HN 2006 Metastatic glucagonoma transforming to insulinoma following chemotherapy. Scott Med J 52:55
27. Schmitt J, Boullu-Sanchis S, Moreau F, Drui S, Louis B, Chabrier G, Pinget M, Jeandidier N 2008 Association of malignant insulinoma and type 2 diabetes mellitus: a case report. Ann Endocrinol (Paris) 69:69-72 (Pubitemid 351467691)
28. Butte JM, Montero PH, Solar A, Torres J, Olmos PR, Goñi I, Quintana JC, Martínez J, Llanos O 2008 Cervical metastases of glucagonoma in a patient with multiple endocrine neoplasia type 1: report of a case. Surg Today 38:1137-1143
29. Roberts RE, Glicksman C, Alaghband-Zadeh J, Sherwood RA, Akuji N, le Roux CW 2011 The relationship between post-prandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol (Oxf) 74:67-72
30. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93:2479-2485 (Pubitemid 352008510)
31. Buteau J, Foisy S, Joly E, Prentki M 2003 Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52:124-132 (Pubitemid 36042116)
32. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJB 2006 Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 93:210-215 (Pubitemid 43259607)
33. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR 2006 Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108-114 (Pubitemid 43054062)
34. Drucker DJ 2006 The biology of incretin hormones. Cell Metab 3:153-165
35. Byrne MM, McGregor GP, Barth P, Rothmund M, Göke B, Arnold R 2001 Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1, GLP-2 and PYY-producing neuroendocrine carcinoma. Digestion 63:61-68 (Pubitemid 32098461)
36. Brubaker PL, Drucker DJ, Asa SL, Swallow C, Redston M, Greenberg GR 2002 Prolonged gastrointestinal transit in a patient with glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumour. J Clin Endocrinol Metab 87:3078-3083 (Pubitemid 34816348)